Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.0.0-ballot - STU 1-ballot United States of America flag

This page is part of the Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

: eCTD Composition for 3.2.S.1 - XML Representation

Raw xml | Download



<Composition xmlns="http://hl7.org/fhir">
  <id value="260f5aa3-23d2-4999-8e5f-70f247390ee5"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s10"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Composition</b><a name="260f5aa3-23d2-4999-8e5f-70f247390ee5"> </a><a name="hc260f5aa3-23d2-4999-8e5f-70f247390ee5"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition &quot;260f5aa3-23d2-4999-8e5f-70f247390ee5&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ectd-composition-32s10.html">eCTD Substance General Information</a></p></div><p><b>identifier</b>: Substance General - levoThyroxine</p><p><b>status</b>: final</p><p><b>type</b>: Substance General Information <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-pqcmc-comp-section-types.html">Code System PQCMC Comp Section Types</a>#32S10)</span></p><p><b>date</b>: 2023-12-15 22:19:47+0000</p><p><b>author</b>: <a href="Bundle-30536c0e-456c-4f90-9f02-da7be1d289e9.html#urn-uuid-b69435a0-45c6-4d44-9fde-b354e17408d7">urn:uuid:b69435a0-45c6-4d44-9fde-b354e17408d7</a></p><p><b>title</b>: eCTD Substance General Information for levoThyroxine</p></div>
  </text>
  <identifier>
    <value value="Substance General - levoThyroxine"/>
  </identifier>
  <status value="final"/>
  <type>
    <coding>
      <system
              value="http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/pqcmc-comp-section-types"/>
      <code value="32S10"/>
      <display value="Substance General Information"/>
    </coding>
  </type>
  <date value="2023-12-15T22:19:47.022Z"/>
  <author>
    <reference value="urn:uuid:b69435a0-45c6-4d44-9fde-b354e17408d7"/>
  </author>
  <title value="eCTD Substance General Information for levoThyroxine"/>
  <section>
    <title
           value="Drug Substance Nomeclature and Structure for levoThyroxine"/>
    <entry>
      <reference value="urn:uuid:21b6b724-507e-4cf4-a462-93334b98d166"/>
    </entry>
  </section>
</Composition>